trending Market Intelligence /marketintelligence/en/news-insights/trending/YzNQ5BvxnIh0JPe2gxeILQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Merrimack appoints president, CEO

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Merrimack appoints president, CEO

Merrimack Pharmaceuticals Inc. appointed Richard Peters as its president and CEO, effective Feb. 6.

Peters will also be appointed a director on the same day. The appointee currently serves as senior vice president and head of global rare diseases at Sanofi Genzyme, a Sanofi subsidiary.

Merrimack's interim president and CEO, Gary Crocker, will continue to serve as the chairman of the board.